glp-1 drugs for inflammation The Era: Why These Intestinal Peptides Are Reshaping Modern Medicine Popular GLP-1 drugs help many

Stemming from successful demonstration of their cardiometabolic modulation and reduction of major adverse cardiovascular events in clinical outcome trials, GLP-1 RAs have since been validated as agents with compelling cardiovascular protective properties

Glucagon-Like Peptide-1, a natural hormone that regulates insulin and appetite

New developments include orally administered GLP1RA, unimolecular glucagon receptor (GCGR)-GLP1R coagonists like survodutide, and GCGR- Gastric Inhibitory Polypeptide Receptor (GIPR)-GLP1R triagonists like retatrutide

Given existing evidence, triple combination therapy can be expected to provide additional cardiorenal protection, although further randomized controlled trials are needed to determine whether triple combination therapy actually has additive or synergetic effects compared with mono or dual therapy

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS According to a press release, the real-world retrospective study included 12,112 patients with the following types of obesity-related cancers, ranging from stage 1 to stage 3